130 related articles for article (PubMed ID: 38401887)
1. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract][Full Text] [Related]
2. A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: Complexity and simplicity in crosstalk.
Ashrafizadeh M; Zhang W; Zou R; Sethi G; Klionsky DJ; Zhang X
Pharmacol Res; 2023 Aug; 194():106822. PubMed ID: 37336429
[TBL] [Abstract][Full Text] [Related]
3. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches.
Ashrafizadeh M; Luo K; Zhang W; Reza Aref A; Zhang X
Environ Res; 2024 Jan; 240(Pt 2):117443. PubMed ID: 37863168
[TBL] [Abstract][Full Text] [Related]
4. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance.
Guo Z; Ashrafizadeh M; Zhang W; Zou R; Sethi G; Zhang X
Cancer Metastasis Rev; 2024 Mar; 43(1):29-53. PubMed ID: 37453022
[TBL] [Abstract][Full Text] [Related]
5. FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA-mediated aerobic glycolysis.
Wu C; Zheng C; Chen S; He Z; Hua H; Sun C; Yu C
Cell Death Dis; 2023 Oct; 14(10):699. PubMed ID: 37875474
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
7. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
[TBL] [Abstract][Full Text] [Related]
8. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway.
Li Z; Huang X; Hu W; Lu H
Tissue Cell; 2022 Aug; 77():101787. PubMed ID: 35623308
[TBL] [Abstract][Full Text] [Related]
10. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
[TBL] [Abstract][Full Text] [Related]
11. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
[TBL] [Abstract][Full Text] [Related]
12. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma.
Chen B; Zhang Q; Wang X; Wang Y; Cui J; Zhuang H; Tang J
Aging (Albany NY); 2020 Feb; 12(4):3647-3661. PubMed ID: 32090981
[TBL] [Abstract][Full Text] [Related]
13. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
[No Abstract] [Full Text] [Related]
14. Long non-coding RNA
Wei Y; Zhu P
Acta Pharm; 2024 Mar; 74(1):131-147. PubMed ID: 38554384
[TBL] [Abstract][Full Text] [Related]
15. MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin β1.
Yang D; Hu Z; Xu J; Tang Y; Wang Y; Cai Q; Zhu Z
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693728
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer.
Jamshed MB; Munir F; Shahid N; Sadiq U; Muhammad SA; Ghanem NB; Zhong H; Li X; Zhang Q
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G109-G119. PubMed ID: 31736340
[TBL] [Abstract][Full Text] [Related]
17. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
18. STMN2 overexpression promotes cell proliferation and EMT in pancreatic cancer mediated by WNT/β-catenin signaling.
Shao M; Wang L; Zhang Q; Wang T; Wang S
Cancer Gene Ther; 2023 Mar; 30(3):472-480. PubMed ID: 36460804
[TBL] [Abstract][Full Text] [Related]
19. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
[TBL] [Abstract][Full Text] [Related]
20. Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer.
Luo W; Zheng L; Zhang TT
Med Oncol; 2021 May; 38(6):74. PubMed ID: 34019188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
